From: Cerebral infarction in advanced non-small cell lung cancer: a case control study
Without CI N = 500 | With CI N = 15 | P | ||
---|---|---|---|---|
Age (year) | Median (range) | 66 (34–92) | 64 (47–78) | 0.39 |
Sex | Male (%) | 293 (58.6 %) | 12 (80.0 %) | 0.11 |
Smoking history | Yes (%) | 316 (63.2 %) | 12 (80.0 %) | 0.19 |
PS | 0,1 (%) | 484 (96.8 %) | 14 (93.3 %) | 0.42 |
Histology | Adenocarcinoma (%) | 411 (82.2 %) | 12 (80.0 %) | 0.66 |
Advanced (%) | 381 (76.2 %) | 12 (80.0 %) | 0.97 | |
Post-operative recurrence (%) | 119 (23.8 %) | 3 (20.0 %) | ||
Hypertension | Yes (%) | 213 (42.6 %) | 7 (46.7 %) | 0.75 |
Diabetes | Yes (%) | 93 (18.1 %) | 2 (13.3 %) | 0.61 |
Old myocardial infarction | Yes (%) | 46 (9.2 %) | 2 (13.3 %) | 0.77 |
Hyperlipidemia | Yes (%) | 95 (18.7 %) | 1 (6.7 %) | 0.25 |
Atrial fibrillation | Yes (%) | 23 (4.5 %) | 1 (6.7 %) | 0.71 |